Brazil authorizes trials with 3rd dose of AstraZeneca COVID vaccine
- Country:
- Brazil
Brazil's health regulator Anvisa said on Monday that it has approved trials with a third dose of the AstraZeneca vaccine against COVID-19.
Anvisa said a third dose of the vaccine would be administered to 10,000 volunteers between 11 and 13 months after the second shot.
ALSO READ
-
IDB Approves $243m to Bring More Reliable Power to Brazil’s Santa Catarina
-
Brazil’s Tax Reform Gets IDB Loans for State Finances and Public Services
-
São Paulo’s $460M Ferry Overhaul Brings Electric Vessels and New Local Jobs
-
Brazil’s Paraíba Secures $50 Million to Build Stronger Water and Sanitation Services
-
AfDB and Brazil Deepen Mali Cooperation on Food, Jobs and Energy
Google News